M&A

Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal
Xconomy
Mon, 06/10/19 - 09:41 am
Merck
M&A
Tilos Therapeutics
cancer immunotherapy
oncology
#BIO2019: Taking the Pulse of Dealmakers: 2019 Outlook
BIOTechNow
Fri, 06/7/19 - 09:59 pm
biotech
M&A
Judge, CVS witness clash on merger settlement, July hearing set
Biopharma Dive
Fri, 06/7/19 - 09:55 pm
M&A
CVS Health
Aetna
FTC
Servier, armed with Shire cancer drugs, builds out vision for U.S. future
Fierce Pharma
Fri, 06/7/19 - 12:47 pm
Servier
oncology
Shire
M&A
Vertex sets sights on DMD gene therapy, joining crowded field
Biopharma Dive
Fri, 06/7/19 - 10:17 am
Vertex Pharmaceuticals
DMD
M&A
CRISPR Therapeutics
Exonics
gene therapy
Germany's Stada buys six of GSK's consumer brands, eyes further deals
Yahoo/Reuters
Fri, 06/7/19 - 10:10 am
generics
Stada
GSK
Europe
M&A
consumer health
BMS reveals its post-Celgene takeover management team
Pharmaforum
Thu, 06/6/19 - 09:30 am
Bristol-Myers Squibb
Celgene
M&A
Nine for 2019: Challenges impacting pharma
Pharmaforum
Wed, 06/5/19 - 10:40 am
global pharma
R&D
M&A
Brexit
Vical finds way out of R&D woes via reverse merger with dermatology biotech Brickell
Endpoints
Mon, 06/3/19 - 08:15 pm
Vical
M&A
Brickell Bio
Bayer's €8B animal health sale stirs up private equity shoppers: FT
Fierce Pharma
Mon, 06/3/19 - 12:42 pm
Bayer
animal health
M&A
CVC
Cinven
Permira
Novartis on goal to hit mid-30s margins by 2022
BioCentury
Sun, 05/26/19 - 11:15 am
Novartis
M&A
Daiichi Sankyo in talks over OTC unit sale – reports
Pharmaforum
Thu, 05/23/19 - 09:56 am
Daiichi Sankyo
M&A
OTC
Amgen offers $167m for drug discovery biotech Nuevolution
Pharmaforum
Wed, 05/22/19 - 10:52 am
Amgen
Nuevolution
R&D
M&A
Merck puts $1B more into oncology, with kidney cancer a focus
Biopharma Dive
Wed, 05/22/19 - 09:52 am
Merck
kidney cancer
M&A
Peloton Therapeutics
Evotec to acquire Gates Foundation-backed Just Biotherapeutics
Fierce Biotech
Tue, 05/21/19 - 10:09 am
Evotec
M&A
Just Biotherapeutics
Opioid Suits Loom Over A Walgreens-AmerisourceBergen Deal
Forbes
Tue, 05/21/19 - 09:36 am
AmerisourceBergen
Walgreens Boots Alliance
M&A
opioids
Merck boosts late-phase cancer pipeline with $1.1B Peloton buy
Fierce Biotech
Tue, 05/21/19 - 09:31 am
Merck
M&A
Peloton Therapeutics
metastatic renal cell carcinoma
Beleaguered Biogen faces the music as a chorus of critics push for a transformative approach to M&A
Endpoints
Tue, 05/21/19 - 09:30 am
Biogen
M&A
aducanumab
Credit Suisse
Hurting for revenue, Mylan shells out $130M for basket of Aspen drugs
Fierce Pharma
Mon, 05/20/19 - 12:24 pm
Mylan
Aspen Pharmacare
M&A
Australia
New Zealand
Where Will Pfizer Be in 5 Years?
Motley Fool
Sat, 05/18/19 - 08:49 pm
Pfizer
M&A
spin-offs
dividends

Pages